BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 16364047)

  • 1. Pharmacological targets in gastro-oesophageal reflux disease.
    Piche T; Galmiche JP
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):333-41. PubMed ID: 16364047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: new pharmacological agents for the treatment of gastro-oesophageal reflux disease.
    Vakil N
    Aliment Pharmacol Ther; 2004 May; 19(10):1041-9. PubMed ID: 15142193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments in the pathophysiology and therapy of gastroesophageal reflux disease and nonerosive reflux disease.
    Tack J
    Curr Opin Gastroenterol; 2005 Jul; 21(4):454-60. PubMed ID: 15930988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress with novel pharmacological strategies for gastro-oesophageal reflux disease.
    Tonini M; De Giorgio R; De Ponti F
    Drugs; 2004; 64(4):347-61. PubMed ID: 14969571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical treatment of GORD. Emerging therapeutic targets and concepts.
    Zerbib F
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):937-46. PubMed ID: 21126705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ; Hunt RH
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New pharmacologic approaches in gastroesophageal reflux disease.
    Armstrong D; Sifrim D
    Gastroenterol Clin North Am; 2010 Sep; 39(3):393-418. PubMed ID: 20951909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological management of GERD: where does it stand now?
    Hershcovici T; Fass R
    Trends Pharmacol Sci; 2011 Apr; 32(4):258-64. PubMed ID: 21429600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: the clinical relevance of transient lower oesophageal sphincter relaxations in gastro-oesophageal reflux disease.
    Kessing BF; Conchillo JM; Bredenoord AJ; Smout AJ; Masclee AA
    Aliment Pharmacol Ther; 2011 Mar; 33(6):650-61. PubMed ID: 21219371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developments in the inhibition of gastric acid secretion.
    Mössner J; Caca K
    Eur J Clin Invest; 2005 Aug; 35(8):469-75. PubMed ID: 16101666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for gastroesophageal reflux disease.
    Boeckxstaens GE
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):481-91. PubMed ID: 19650746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.
    Robinson M
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():1-10. PubMed ID: 15496213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel approaches to the pharmacological blockade of gastric acid secretion.
    Parsons ME; Keeling DJ
    Expert Opin Investig Drugs; 2005 Apr; 14(4):411-21. PubMed ID: 15882117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reflux inhibitors: a new approach for GERD?
    Boeckxstaens GE
    Curr Opin Pharmacol; 2008 Dec; 8(6):685-9. PubMed ID: 18771751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical therapy of gastroesophageal reflux disease.
    Coron E; Hatlebakk JG; Galmiche JP
    Curr Opin Gastroenterol; 2007 Jul; 23(4):434-9. PubMed ID: 17545782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel treatments of GERD: focus on the lower esophageal sphincter.
    Lehmann A
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():103-10. PubMed ID: 18924449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: the role of bile and pepsin in the pathophysiology and treatment of gastro-oesophageal reflux disease.
    Tack J
    Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 2():10-6. PubMed ID: 16939428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease.
    Katz PO; Tutuian R
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):371-84. PubMed ID: 11403533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroesophageal reflux disease.
    Armstrong D
    Curr Opin Pharmacol; 2005 Dec; 5(6):589-95. PubMed ID: 16214410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights in the neural regulation of the lower oesophageal sphincter.
    Blackshaw LA
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():33-9. PubMed ID: 18924442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.